Natixis Advisors L.P. Has $3.73 Million Stake in Exponent, Inc. (NASDAQ:EXPO)

Natixis Advisors L.P. lowered its stake in shares of Exponent, Inc. (NASDAQ:EXPO) by 8.3% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 37,409 shares of the business services provider’s stock after selling 3,407 shares during the period. Natixis Advisors L.P. owned about 0.07% of Exponent worth $3,729,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of EXPO. Norges Bank acquired a new stake in shares of Exponent during the 4th quarter valued at $51,619,000. Morgan Stanley boosted its stake in shares of Exponent by 87.7% during the 4th quarter. Morgan Stanley now owns 1,057,052 shares of the business services provider’s stock valued at $104,743,000 after buying an additional 493,847 shares during the period. Citadel Advisors LLC boosted its stake in shares of Exponent by 550.2% during the 2nd quarter. Citadel Advisors LLC now owns 172,567 shares of the business services provider’s stock valued at $15,785,000 after buying an additional 146,028 shares during the period. GW&K Investment Management LLC boosted its stake in shares of Exponent by 16.8% during the 1st quarter. GW&K Investment Management LLC now owns 631,494 shares of the business services provider’s stock valued at $62,954,000 after buying an additional 90,752 shares during the period. Finally, Thematics Asset Management acquired a new stake in shares of Exponent during the 4th quarter valued at $7,927,000. Institutional investors and hedge funds own 89.31% of the company’s stock.

Insiders Place Their Bets

In other Exponent news, VP Steven J. Murray sold 1,000 shares of the business’s stock in a transaction on Monday, August 21st. The shares were sold at an average price of $89.50, for a total transaction of $89,500.00. Following the completion of the transaction, the vice president now owns 27,412 shares of the company’s stock, valued at approximately $2,453,374. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 2.20% of the company’s stock.

Exponent Trading Down 1.4 %

EXPO stock opened at $89.86 on Friday. The firm has a market cap of $4.57 billion, a PE ratio of 45.61 and a beta of 0.62. Exponent, Inc. has a 1 year low of $85.27 and a 1 year high of $112.75. The company has a fifty day simple moving average of $91.70 and a 200 day simple moving average of $95.15.

Exponent (NASDAQ:EXPO) last released its earnings results on Thursday, July 27th. The business services provider reported $0.50 earnings per share for the quarter, missing analysts’ consensus estimates of $0.51 by ($0.01). The firm had revenue of $129.65 million for the quarter, compared to analyst estimates of $130.40 million. Exponent had a return on equity of 30.41% and a net margin of 19.03%. The firm’s revenue was up 9.7% on a year-over-year basis. During the same period in the prior year, the firm earned $0.49 EPS. As a group, analysts forecast that Exponent, Inc. will post 2.05 EPS for the current fiscal year.

Exponent Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, September 22nd. Shareholders of record on Friday, September 8th will be given a dividend of $0.26 per share. This represents a $1.04 dividend on an annualized basis and a yield of 1.16%. The ex-dividend date is Thursday, September 7th. Exponent’s dividend payout ratio is 52.79%.

Wall Street Analyst Weigh In

EXPO has been the subject of a number of research reports. TheStreet lowered shares of Exponent from a “b” rating to a “c+” rating in a research note on Wednesday, May 17th. Truist Financial reduced their price objective on shares of Exponent from $120.00 to $110.00 and set a “buy” rating for the company in a research note on Monday, July 31st. StockNews.com initiated coverage on shares of Exponent in a research note on Thursday, August 17th. They issued a “hold” rating for the company. Finally, UBS Group initiated coverage on shares of Exponent in a research note on Wednesday, May 31st. They issued a “neutral” rating and a $99.00 price objective for the company. Three analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $104.50.

Exponent Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.